หน้าแรก
ค้นหา
DESTINY Breast 03 from #ESMO21 presenter Dr. Erika Hamilton
No description available
แสดงข้อมูลเพิ่มเติม 1
DESTINY Breast 03 from #ESMO21 presenter Dr. Erika Hamilton
Dr. Erika P. Hamilton on ONT-380 in HER2-Positive Breast Cancer Patients With Brain Metastases
#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer
Highlights from ESMO: DESTINY-Breast03
Choosing between tucatinib and T-DXd in HER2+ breast cancer
#ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancers
Dr. Hamilton on the Efficacy of Trastuzumab Deruxtecan in HER2-Low Breast Cancer
Breast cancer research at ESMO 2021
DESTINY-Breast03: practice-changing results from ESMO 2021
DESTINY-Breast03: T-DXd is superior to T-DM1 in HER2+ metastatic breast cancer
Breast cancer trial updates at ESMO 2021
The evolution of advanced breast cancer management
Breast cancer at ESMO 2020: IMpassion131, SOLAR-1, PALLAS and more
Esmo Breast Cancer 2021: analysis of two important studies presented during the congress
Prostate cancer picks from #ESMO21 from Dr. Axel Merseburger
Trastuzumab deruxtecan in patients with breast cancer and brain metastases in DESTINY-Breast01
HER2CLIMB and NALA Trials: R/R HER2+ mBC
Ian Krop MD, PhD shares results from the phase 2 DESTINY-01 at SABCS 2019
2019 Sarah Cannon Broadcast Media Highlights
Dr. Matteo Lambertini Discusses IMpassion031 presented at #ESMO20 with OncoAlert
